Fresenius Kabi USA Issues Voluntary Nationwide Recall

Fresenius Kabi USA has initiated a voluntary recall of four lots of benztropine mesylate injection in 2-mL vials due to the possibility of glass particles in the vials.
The Wall Street Journal